Uridine Suppresses ROS-Driven Osteoclast Differentiation and Mitigates Osteoporosis Through PI3K/Akt–FoxO Pathway Modulation - Top-Institutions - MDSpire

Uridine Suppresses ROS-Driven Osteoclast Differentiation and Mitigates Osteoporosis Through PI3K/Akt–FoxO Pathway Modulation

  • By

  • Sijie Bian

  • Lianhui Zhao

  • Xu Wang

  • Zhangwei Wu

  • Maolin Yang

  • Jianliang Ou

  • Tao Han

  • Faxue Liao

  • Qingkai Xue

  • Xingxing Huo

  • Jun Chang

  • April 27, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Osteoporosis
    • Bone Metabolism
    • Endocrinology

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Bone Biology
    • Endocrinology
    • Metabolic Diseases

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Osteoporosis
    • Bone Remodeling
    • Molecular Biology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Bone Metabolism
    • Endocrinology
    • Cell Signaling

  • #5

    University of Michigan
    University of Michigan

    Ann Arbor, MI

    Key Differentiators

    • Bone Biology
    • Metabolic Bone Disease
    • Molecular Endocrinology

Original Source(s)

Uridine Suppresses ROS-Driven Osteoclast Differentiation and Mitigates Osteoporosis Through PI3K/Akt–FoxO Pathway Modulation

  • by Sijie Bian, Lianhui Zhao, Xu Wang, Zhangwei Wu, Maolin Yang, Jianliang Ou, Tao Han, Faxue Liao, Qingkai Xue, Xingxing Huo, Jun Chang

  • April 27, 2026

Related Content

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

Lower odds of prevalent vertebral fractures with b/tsDMARD use among rheumatoid arthritis patients in clinical remission: a retrospective observational study

Current Insights into Osteoporosis Linked to Endocrine Disorders